Johnson & Johnson · NYSE:JNJ

Johnson & Johnson — Fact Sheet (March 2023)

4 slides from Johnson & Johnson's fact sheet, March 2023

  1. Slide 1: References and last updated March 2023

    1. WHO Global Tuberculosis Report 2022. Available here: https://www.who.int/publications/i/item/9789240061729 Last accessed 27 October 2022. 2. Stop TB Partnership Report: The Potential Impact of the COVID-19 Response on Tuberculosis in High-Burden Countries: A Modelling Analysis. Available here: ht

  2. Slide 2: 10-Year Commitment Highlights

    10-YEAR COMMITMENT HIGHLIGHTS As part of our 10-year TB initiative, Johnson & Johnson is working closely with governments, national TB programs and local partners in high-burden countries to help end TB across three kill pillars: | Working in collaboration over the last 10 years to facilitate access

  3. Slide 3: Our Partnerships

    OUR PARTNERSHIPS Johnson & Johnson is engaged in a wide range of TB collaborations to help drive impact in high-burden countries, including: Delivering Since 2015, Johnson & Johnson has worked with the Stop TB Partnership’s Global se Drug Facility to deliver our MDR-TB medicine to those in need, inc

  4. Slide 4: We cannot end the TB epidemic with today's tools alone

    Despite the positive impact of our efforts, we cannot end the TB epidemic with today’s tools alone. Achieving the global goal of ending TB and addressing the urgent threat of antimicrobial resistance will ultimately require significant innovation. We have made important progress, but must continue s

Johnson & Johnson — Fact Sheet (March 2023) on 6ix